<SEC-DOCUMENT>0001651308-18-000014-index.html : 20181212
<SEC-HEADER>0001651308-18-000014.hdr.sgml : 20181212
<ACCEPTANCE-DATETIME>20181211173656
ACCESSION NUMBER:		0001651308-18-000014
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20181211
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
FILED AS OF DATE:		20181212
DATE AS OF CHANGE:		20181211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BeiGene, Ltd.
		CENTRAL INDEX KEY:			0001651308
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37686
		FILM NUMBER:		181229597

	BUSINESS ADDRESS:	
		STREET 1:		C/O MOURANT OZANNES CORPORATE SERVICES
		STREET 2:		94 SOLARIS AVENUE, CAMANA BAY
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1108
		BUSINESS PHONE:		13459494123

	MAIL ADDRESS:	
		STREET 1:		C/O MOURANT OZANNES CORPORATE SERVICES
		STREET 2:		94 SOLARIS AVENUE, CAMANA BAY
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1108
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bgne-xform8xkreegmxxfinal1.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: bgne-xform8xkreegmxxfinal1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>fiftharmafinal.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
Document 2 - file: fiftharmafinal.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>appendixb-2ndar2016planfin.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
Document 3 - file: appendixb-2ndar2016planfin.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>appendixc-2nda_r2018esppfi.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
Document 4 - file: appendixc-2nda_r2018esppfi.htm

</DOCUMENT>
</SEC-DOCUMENT>